Sanofi Extends $69-Per-Share Tender Offer For Genzyme To Jan. 21

Less than 1% of outstanding shares had been tendered as of Dec. 10 deadline.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet